Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil.

Feliciano CS, Menon LJB, Anselmo LMP, Dippenaar A, Warren RM, Silva WA Jr, Bollela VR.

ERJ Open Res. 2019 Aug 5;5(3). pii: 00043-2019. doi: 10.1183/23120541.00043-2019. eCollection 2019 Jul.

2.

Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.

Feliciano CS, Namburete EI, Rodrigues Pla├ža J, Peronni K, Dippenaar A, Warren RM, Silva WA Jr, Bollela VR.

Tuberculosis (Edinb). 2018 May;110:59-67. doi: 10.1016/j.tube.2018.04.003. Epub 2018 Apr 5.

PMID:
29779775
3.

Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.

Bollela VR, Namburete EI, Feliciano CS, Macheque D, Harrison LH, Caminero JA.

Int J Tuberc Lung Dis. 2016 Aug;20(8):1099-104. doi: 10.5588/ijtld.15.0864.

4.

Role of a GenoType MTBDRplus line probe assay in early detection of multidrug-resistant tuberculosis at a Brazilian reference center.

Feliciano CS, Nascimento MM, Anselmo LM, Pocente RH, Bellissimo-Rodrigues F, Bollela VR.

Braz J Med Biol Res. 2015 Aug;48(8):759-64. doi: 10.1590/1414-431X20154458. Epub 2015 Jun 30.

5.

Constitutive expression of E2F-1 leads to p21-dependent cell cycle arrest in S phase of the cell cycle.

Radhakrishnan SK, Feliciano CS, Najmabadi F, Haegebarth A, Kandel ES, Tyner AL, Gartel AL.

Oncogene. 2004 May 20;23(23):4173-6.

PMID:
15048076
6.

Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage.

Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A, Hay N.

Mol Cell Biol. 2002 Nov;22(22):7831-41.

Supplemental Content

Loading ...
Support Center